2026 Traceability Seminar

Back to upcoming events

2026 Traceability Seminar

August 31 - September 2, 2026 | Marriott Marquis Washington, DC

29

Days
12

Hours
23

Minutes

Speakers

Ameer Ali

Sr. Director, Manufacturer Operations & Data Services

Cencora, Inc.
- Readying Supply Chain Systems and Packaging to Transact NDC-12
  Tuesday, September 1, 2026 | 4:30—5:30 PM
  
  Liberty Ballroom
Ameer Ali

Sr. Director, Manufacturer Operations & Data Services

Cencora, Inc.
- Readying Supply Chain Systems and Packaging to Transact NDC-12
  Tuesday, September 1, 2026 | 4:30—5:30 PM
  
  Liberty Ballroom
Ameer Ali is Sr. Director of Manufacturer Operations at Cencora. He joined Cencora in 2015 to support DSCSA related process implementations with responsibilities spanning both data exchange and barcode compliance as well as other non-DSCSA EDI and packaging functions. He participates regularly in industry groups to support process efficiency and best practices across the supply chain. These groups include HDA DSCSA exceptions, HDA Research Foundation, GS1 Rx Secure Supply Chain and GS1 GLN workgroups among others. He also took part in many industry pilots and FDA public meetings in preparation for phased implementation of DSCSA.
Cathy Barbic

Associate Director, Supply Chain Projects and Compliance

Novo Nordisk Inc.
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
Cathy Barbic

Associate Director, Supply Chain Projects and Compliance

Novo Nordisk Inc.
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
Cathy Barbic is an Associate Director of Supply Chain Projects and Compliance at Novo Nordisk Inc. Cathy is
responsible for managing and implementing supply chain initiatives in the US including compliance and traceability. Cathy was part of the initial lot traceability effort and co-managed the US serialization project to ensure compliance with the US Drug Supply Chain Security Act (DSCSA) requirements. Cathy works closely with US internal stakeholders, the Novo Nordisk Global Serialization program, solution providers, and trading partners to lead the continuing effort of compliance with DSCSA regulations. She also continues to be involved with various business areas and IT to find solutions to new challenges in serialization.

Cathy’s other responsibilities include managing cross-functional teams for new product launches and she is currently involved in many other company initiatives.

Cathy has worked for Novo Nordisk Inc. for 17 years. Prior to working in the pharmaceutical industry, Cathy
worked in the consumer products industry and was a management consultant leading Order to Cash teams implementing ERP systems.
Ilisa B.G. Bernstein

President

Bernstein Rx Solutions, LLC
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Ilisa B.G. Bernstein

President

Bernstein Rx Solutions, LLC
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Ilisa Bernstein, PharmD, JD, FAPhA, is President of Bernstein Rx Solutions, LLC, assisting clients in understanding and maneuvering through drug and pharmacy regulatory policy and compliance issues, strategies, and advocacy. She brings over 35 years of experience and expertise in the government, non-profit, and private sectors in achieving successful outcomes and advancing innovation.

Dr. Bernstein spent nearly 5 years at the American Pharmacists Association (APhA). For 13 months, she served as the 14th CEO and Executive Vice President of APhA, the first woman to lead as CEO in the 172-year history of the association. She led all operations and strategies for APhA, the Board of Pharmacy Specialties, and the APhA Foundation. She joined APhA in 2019 as Senior Vice President for Pharmacy Practice & Government Affairs and guided APhA as the voice of pharmacists in all practice settings.

For over 30 years, Dr. Bernstein held several senior leadership positions at the U.S. Food and Drug Administration (FDA). Notably, she was deputy director of FDA’s Office of Compliance in the Center for Drug Evaluation & Research, leading policies, compliance, and enforcement for drugs and for 19 years she had several senior policy advisor roles in the Office of the Commissioner. She started at FDA as a clinical pharmacology reviewer.
Recognized for her achievements, she proudly received the 2023 Distinguished Alumni Lifetime Achievement Award from the University of Michigan College of Pharmacy and was chosen as one of the 2023 Top 50 Most Influential Leaders in Pharmacy.

Dr. Bernstein was also senior associate director of worldwide regulatory affairs at Pfizer and completed a post-doctoral clinical residency at the National Institutes of Health. She earned her Doctor of Pharmacy from the University of Michigan College of Pharmacy and her Juris Doctor from American University Washington College of Law.
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- Readying Supply Chain Systems and Packaging to Transact NDC-12
  Tuesday, September 1, 2026 | 4:30—5:30 PM
  
  Liberty Ballroom
Ian Cannell

Business Process Consultant / DSCSA National Project Sponsor

Kaiser Permanente
- Readying Supply Chain Systems and Packaging to Transact NDC-12
  Tuesday, September 1, 2026 | 4:30—5:30 PM
  
  Liberty Ballroom
Ian Cannell proudly represents Kaiser Permanente and continues to lead DSCSA readiness efforts across the Program.
With more than 25 years of healthcare, systems and patient case management experience, he is implementing a standardized, robust and cost-effective solution to keep Kaiser Permanente compliant in 2025 and beyond.
Libby Dewey

Manager, DSCSA

Cardinal Health, Inc.
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Libby Dewey

Manager, DSCSA

Cardinal Health, Inc.
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Liberty (Libby) Dewey is the Manager of the DSCSA Center of Excellence at Cardinal Health, where she leads cross-functional efforts to develop the systems, processes, and capabilities necessary to support compliance with the Drug Supply Chain Security Act (DSCSA). Throughout her 23-year career with Cardinal Health, she has held leadership and subject matter expert roles across both the Pharmaceutical and Medical segments, building expertise in regulatory affairs, operations, strategic sourcing, and technology transformation.

Over the past eight years, Liberty has served as a lead DSCSA Subject Matter Expert, helping design and implement enterprise-wide solutions and business processes to meet evolving regulatory requirements and strengthen supply chain interoperability. Her experience includes serving as a business SME for large-scale Procure-to-Pay system transformations and leading initiatives that bring together diverse stakeholders to achieve successful end-to-end outcomes.

An active participant in industry collaboration efforts, Liberty contributes to several key groups shaping the future of pharmaceutical traceability and supply chain security, including the HDA Traceability Work Group, GS1 Rx Secure Supply Chain, the Partnership for DSCSA Governance (PDG), and the Pharmaceutical Distribution Security Alliance (PDSA). She is also a returning HDA conference speaker, bringing practical insights from both operational execution and industry engagement.

Liberty holds a Bachelor of Arts in Business and Philosophy from Ashland University and an MBA from The Ohio State University with a focus on Operations and Lean Six Sigma.

Outside of work, Liberty is a proud mother of two, Jacob (13) and Isabel (9). When she is not attending sporting events and activities with her children, she enjoys reading, strength training, and distance running. She is currently pursuing her goal of completing a half marathon in all 50 states, with only five states remaining.
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
Gregg A. Gorniak

VP - Manufacturer Operations & Data Services | Secure Supply Chain Lead

Cencora, Inc.
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
Gregg is currently Vice President – Manufacturer Operations & Data Services and Secure Supply Chain Lead for Cencora (formerly AmerisourceBergen). The SSC project team is delivering the Track & Trace and serialization requirements of the DSCSA. Gregg’s focus is currently on Manufacturer & Customer onboarding activities as well as DC activation for inbound scanning at receiving, returns, and exception handling while also sending outbound EPCIS messages to downstream trading partners.

Prior to AB, Gregg was the US Serialisation Lead at GSK leading the work on the DSCSA saleable returns project and developing GSK’s long-term solution for the DSCSA requirements in 2023. At GSK, Gregg held positions ranging from Analytics Reporting Manager in R&D Clinical Operations, Data Lead for the US SAP implementation, and Director of Data Quality in the Transparency Data Operations & Reporting team in Pharma Finance. Prior to GSK, Gregg worked for 6 years at Pfizer in Global Logistics & Supply in the Enterprise Data Management group focused on SAP Material Master.

Gregg has almost 25 years of experience in multiple Leadership & Senior Data roles in both the Pharmaceutical, Finance, and Software industries. Gregg holds an MBA in Management from Saint Joseph’s University’s Haub School of Business and a BS in Business Administration from Rider University. Gregg has a passion for data, systems, & business processes and strives to work towards solutions that benefit all.
Frank Gunson

Vice President, Regulatory Affairs & Patient Safety

McKesson Corporation
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Frank Gunson

Vice President, Regulatory Affairs & Patient Safety

McKesson Corporation
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Justin Macy

Director of Innovation

National Association of Boards of Pharmacy®
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Justin Macy

Director of Innovation

National Association of Boards of Pharmacy®
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Justin specializes in the intersection of law, technology, and healthcare with a focus on pharmacy practice and drug regulation. Recently, Justin helped lead NABP’s DSCSA efforts to support regulators, dispensers, and other trading partners by providing tools and education which enable implementation of DSCSA’s interoperability milestone (Pulse by NABP). Historically, Justin has worked closely with NABP's Digital Health team. Prior to joining NABP, Justin was a specialist in Amazon’s Consumer Legal Department and Associate Director of Innovation for a tech start-up.
David G. Mason

Director of Supply Chain Compliance

Novartis Pharmaceuticals Corporation
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
David G. Mason

Director of Supply Chain Compliance

Novartis Pharmaceuticals Corporation
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
  Tuesday, September 1, 2026 | 3:30—4:30 PM
  
  Liberty Ballroom
Dave Mason is currently the Director of Supply Chain compliance and Serialization – Dave supports the Commercial Trade and Supply Chain teams, supporting the implementation of DSCSA for the Novartis group. Leading efforts to assure Novartis error rates are six sigman or less by assuring procedures are in place for serialization data quality and integrity, improving existing serialization processes and systems as information is provided by supply chain partners on the DSCSA processes. Dave represents Novartis in trade association, PDG and FDA public meetings. He communicates to the NTO Global Serialization team with new and existing requirements for other countries, and he assures that the validation approach is consistent within the organization and execution at the sites. Dave also supports the team to develop to support serialization as it is integrated into the normal business processes. Dave has worked on serialization since 2003 in California and helped implement global solutions.
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Michael J. Mazur

Director, Trade Operations

Pfizer Inc.
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Mike’s responsibilities include developing and implementing strategies to enhance patient safety and further secure the U.S. pharmaceutical supply chain. He represents Pfizer externally on various customer engagements and industry interactions related to channel security and works closely with internal Pfizer colleagues to implement approved strategies. Mike has been directly involved with Pfizer’s global projects to implement serialization and is responsible for ensuring compliance with the U.S. Drug Supply Chain Security Act (DSCSA) requirements. He also works closely with Pfizer’s Global Security organization as it relates to investigations of suspected counterfeit or adulterated Pfizer products and is an active member of GS1 US Healthcare, Pharmaceutical Distribution Security Alliance (PDSA) and the Partnership for DSCSA Governance (PDG). Mike has worked within the pharmaceutical industry for over 31 years with most of that time spent in trade operations at Pfizer.
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Scott A. Mooney

Vice President Distribution Operations, Traceability

McKesson Corporation
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Scott Mooney is Vice President of Distribution Operations at McKesson Corporation. His primary responsibilities are assuring product integrity through regulatory compliance and traceability. Scott leads McKesson’s Traceability Team working on implementation across McKesson’s various business units.

Scott joined McKesson in 1987 and had previous roles in Finance, Distribution Center Management and as a Regional Vice President of Distribution Operations. Scott has participated in McKesson’s integration of acquisitions over the last 16 years.

Scott has been active in HDA’s Traceability Workgroup, the HDA Industry Relations Council and participates in several committees including the FGAC, RAC and SGAC. He is tri-chair of GS1 Global Healthcare Leadership Team and is a member of the GS1 US Healthcare Executive Leadership Committee. Scott is serving as a member of the Board of Directors of the Partnership for DSCSA Governance as well.

Scott has a BA in Accountancy and a MBA from the University of Wisconsin – La Crosse.
Sean Murphy

Senior Manager, Manufacturer Operations

Cencora, Inc.
- Barcode Scanning and EDI Transaction Errors
  Wednesday, September 2, 2026 | 9:45—10:45 AM
  
  Liberty Ballroom
Sean Murphy

Senior Manager, Manufacturer Operations

Cencora, Inc.
- Barcode Scanning and EDI Transaction Errors
  Wednesday, September 2, 2026 | 9:45—10:45 AM
  
  Liberty Ballroom
Sean Murphy has been with Cencora, a global leader in pharmaceutical solutions, for over 10 years. He started in Replenishment Operations where he focused on demand planning and analytics. For the past eight years, Sean has worked on implementation of the Drug Supply Chain Security Act (DSCSA) helping to ensure compliance and improve traceability within the pharmaceutical supply chain.
Sean brings a practical understanding of supply chain operations and regulatory requirements with a focus on implementing solutions that enhance efficiency and support industry standards.
Arthi Nagaraj

Head of Analytics, Strategic Projects and Serialization

Sanofi US
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Arthi Nagaraj

Head of Analytics, Strategic Projects and Serialization

Sanofi US
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Arthi Nagaraj is part of the North America Supply Chain team at Sanofi and leads their analytics and serialization efforts. She supports all 3 Business units within Sanofi: General Medicine, Specialty Care and Vaccines, in their efforts to be ready for DSCSA. She also serves on the Board of PDG (Partnership for DSCSA Governance) and co-chairs the TI/TS workgroup under PDG. She is actively involved in the industry forums for DSCSA including participating in the Pilot project program with the FDA. Arthi is a vocal proponent of Diversity, Equity, and Inclusion (DEI) and serves as part of the leadership team for DEI in North America Supply Chain and the CAN (Capable and Able Network) ERG at Sanofi..

Prior to Sanofi, Arthi has worked in both Manufacturing and Supply Chain at Agfa Corporation leading the Regional S&OPs for the US Business. Prior to her experience in Supply Chain, she has over 7 years of experience working in the IT industry developing, leading, and coordinating projects in diverse sectors such as Finance, Telecom and Energy.

Arthi has a bachelor's degree in Computer Science Engineering and an MBA in Supply Chain Management from Lehigh University.
Leyla Rahjou-Esfandiary

Branch Chief, Center for Drug Evaluation and Research

U.S. Food and Drug Administration
- FDA Drug Identification Update: Preparing for NDC and Barcode Modernization
  Wednesday, September 2, 2026 | 8:30—9:30 AM
  
  Liberty Ballroom
Leyla Rahjou-Esfandiary

Branch Chief, Center for Drug Evaluation and Research

U.S. Food and Drug Administration
- FDA Drug Identification Update: Preparing for NDC and Barcode Modernization
  Wednesday, September 2, 2026 | 8:30—9:30 AM
  
  Liberty Ballroom
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
- The Three-Year NDC-12 Transition Period
Jaidalyn Rand

Director, Industry Relations

Healthcare Distribution Alliance
- Transforming DSCSA Compliance Into Strategic Growth and Innovation
- The Three-Year NDC-12 Transition Period
Lisa Schwartz

Senior Director, Professional Affairs

National Community Pharmacists Association
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Lisa Schwartz

Senior Director, Professional Affairs

National Community Pharmacists Association
- The Three-Year NDC-12 Transition Period
  Wednesday, September 2, 2026 | 10:45—12:00 PM
  
  Liberty Ballroom
Lisa is knowledgeable on pharmacy practice issues including pharmacy operations, pharmacy quality measurement, DSCSA, pharmacy automation, and health IT. She utilizes her unique skills to support pharmacy owners nationwide on a variety of practice transformation and business issues.
April Anne Sese

DSCSA Lead, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- Barcode Scanning and EDI Transaction Errors
  Wednesday, September 2, 2026 | 9:45—10:45 AM
  
  Liberty Ballroom
April Anne Sese

DSCSA Lead, Digital Identification & Traceability

Johnson & Johnson Supply Chain
- Barcode Scanning and EDI Transaction Errors
  Wednesday, September 2, 2026 | 9:45—10:45 AM
  
  Liberty Ballroom
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Kala Shankle

Vice President, Regulatory Affairs

Healthcare Distribution Alliance
- Beyond Traceability: Preparing for National Licensure Standards
  Tuesday, September 1, 2026 | 10:15—11:15 AM
  
  Liberty Ballroom
Kala Shankle is Vice President of Regulatory Affairs. In this role, Shankle leads HDA’s regulatory activities and engagement for members’ priority issues.

Prior to joining HDA, Shankle was an attorney at Epstein, Becker and Green, where she counseled pharmaceutical supply chain stakeholders on regulatory and compliance matters. Previously, Shankle provided legal counsel, developed policy solutions and led regulatory engagement for the National Association of Chain Drug Stores (NACDS), the National Community Pharmacists Association (NCPA) and a state pharmacy association in Florida.

She received both her Juris Doctor and Bachelor of Science from Florida State University. She is a Board member for the American Society for Pharmacy Law.
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
- Readying Supply Chain Systems and Packaging to Transact NDC-12
Tim Stearns

Senior Director, Industry Relations

Healthcare Distribution Alliance
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
- Readying Supply Chain Systems and Packaging to Transact NDC-12
Tim Stearns is a Senior E-Commerce Analyst with Baxter HealthCare, focusing primarily on the distributor customer base. With over 22 years of experience in information systems, he has integrated back–end systems and implemented numerous EDI transaction sets focused on contract/chargeback administration, customer credit and invoicing, returns processing, order management and shipping notices, track–and–trace /pedigree systems design, customer–to–HIN alignment with HIBCC and distributor Fee for Service/inventory management agreements. Tim has served twice as co–chair of the HDMA Business Technology Committee, member of the HDMA eCommerce Task Force, member of the CSOS Working Group and the Health Industry Business Communications Council E-Business Council.
Aaron Weisbuch

Senior Regulatory Advisor, CDER

U.S. Food and Drug Administration
- FDA DSCSA Update: Enforcement Priorities and Supply Chain Readiness
  Tuesday, September 1, 2026 | 8:45—9:45 AM
  
  Liberty Ballroom
Aaron Weisbuch

Senior Regulatory Advisor, CDER

U.S. Food and Drug Administration
- FDA DSCSA Update: Enforcement Priorities and Supply Chain Readiness
  Tuesday, September 1, 2026 | 8:45—9:45 AM
  
  Liberty Ballroom
Aaron Weisbuch is a Senior Regulatory Advisor at the United States, Food and Drug Administration in CDER’s Office of Drug Security, Integrity, and Response (ODSIR) where he focuses on policy and compliance issues related to prescription drugs, the pharmaceutical supply chain, and implementation of the Drug Supply Chain Security Act.
Prior to joining ODSIR, Aaron served as Regulatory Counsel in CDER’s Office of Unapproved Drugs and Labeling Compliance and in the Center for Tobacco Products. Aaron is a graduate of San Diego State University and American University Washington College of Law.
Ervin West

Supply Chain Lead DSCSA Compliance

CenterWell Pharmacy
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Ervin West

Supply Chain Lead DSCSA Compliance

CenterWell Pharmacy
- Drop-Ship and 340B Complexities Unpacked: Insights and Shared Solutions
  Tuesday, September 1, 2026 | 11:20—12:20 PM
  
  Liberty Ballroom
Ervin is currently the DSCSA Compliance Lead at CenterWell Pharmacy within the Inventory Procurement team.
When he joined the pharmaceutical industry with CenterWell in late 2012, he brought long term expertise in Supply Chain systems and Logistics management to his current role. Since early 2013, he has been instrumental in the creation and adoption of processes and procedures, along with system upgrades to help ensure success in CenterWell’ s compliance efforts. His primary responsibilities are focused on continual DSCSA support and ongoing educational opportunities for all CenterWell dispensing facilities.

Prior to joining CenterWell he was a senior implementation consultant specializing in DMS/WMS and space planning software for a large international solution provider.
Kelly Wilson

Branch Chief, Prescription Drugs Branch, Office of Unapproved Drugs and Labeling Compliance

U.S. Food and Drug Administration
- FDA Drug Identification Update: Preparing for NDC and Barcode Modernization
  Wednesday, September 2, 2026 | 8:30—9:30 AM
  
  Liberty Ballroom
Kelly Wilson

Branch Chief, Prescription Drugs Branch, Office of Unapproved Drugs and Labeling Compliance

U.S. Food and Drug Administration
- FDA Drug Identification Update: Preparing for NDC and Barcode Modernization
  Wednesday, September 2, 2026 | 8:30—9:30 AM
  
  Liberty Ballroom

We use cookies, pixels and other technology to understand our users better and ensure that we give you the best experience on our website.

2026 Traceability Seminar

August 31 - September 2, 2026 | Marriott Marquis Washington, DC

2026 Traceability Seminar

August 31 - September 2, 2026 | Marriott Marquis Washington, DC

29

12

23

Speakers

Ameer Ali

Ameer Ali

Cathy Barbic

Cathy Barbic

Ilisa B.G. Bernstein

Ilisa B.G. Bernstein

Ian Cannell

Ian Cannell

Libby Dewey

Libby Dewey

Gregg A. Gorniak

Gregg A. Gorniak

Frank Gunson

Frank Gunson

Justin Macy

Justin Macy

David G. Mason

David G. Mason

Michael J. Mazur

Michael J. Mazur

Scott A. Mooney

Scott A. Mooney

Sean Murphy

Sean Murphy

Arthi Nagaraj

Arthi Nagaraj

Leyla Rahjou-Esfandiary

Leyla Rahjou-Esfandiary

Jaidalyn Rand

Jaidalyn Rand

Lisa Schwartz

Lisa Schwartz

April Anne Sese

April Anne Sese

Kala Shankle

Kala Shankle

Tim Stearns

Tim Stearns

Aaron Weisbuch

Aaron Weisbuch

Ervin West

Ervin West

Kelly Wilson

Kelly Wilson